A new option

pharmacist holding script, medicine
New fixed-dosed two-drug regimen approved for HIV—reducing patient exposure and potential drug interactions compared to usual pills containing three or more medicines The TGA has approved Dovato (dolutegravir and lamivudine), a new once-daily, single-tablet, two-drug regimen for treatment-naïve adults and adolescents with human immunodeficiency virus infection type 1 (HIV-1). Studies show that that Dovato, containing

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacy-based practitioner recognised
Next This will be the century of pharmacists: FIP